Basit öğe kaydını göster

dc.contributor.authorOzekmekci, S
dc.contributor.authorApaydin, Hülya
dc.contributor.authorAltinel, Ahmet
dc.contributor.authorVural, M
dc.date.accessioned2021-03-05T12:31:42Z
dc.date.available2021-03-05T12:31:42Z
dc.date.issued2003
dc.identifier.citationVural M., Ozekmekci S., Apaydin H., Altinel A., "High-dose piracetam is effective on cerebellar ataxia in a patient with cerebellar cortical atrophy", MOVEMENT DISORDERS, cilt.18, ss.457-459, 2003
dc.identifier.issn0885-3185
dc.identifier.otherav_ad990b05-4a8a-4e23-ba1e-b7836c346e51
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/115823
dc.identifier.urihttps://doi.org/10.1002/mds.10364
dc.description.abstractWe describe a patient with cerebellar ataxia of degenerative nature who was administered high-dose piracetam in a single-blind trial. Piracetam was demonstrated to be highly effective on tandem gait and gait ataxia in daily doses of 60 g. We suggest piracetam has a potential anti-ataxic effect in human cerebellar ataxia when used in considerably higher doses than those indicated for other purposes. (C) 2003 Movement Disorder Society.
dc.language.isoeng
dc.subjectNöroloji
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectKLİNİK NEUROLOJİ
dc.titleHigh-dose piracetam is effective on cerebellar ataxia in a patient with cerebellar cortical atrophy
dc.typeMakale
dc.relation.journalMOVEMENT DISORDERS
dc.contributor.department, ,
dc.identifier.volume18
dc.identifier.issue4
dc.identifier.startpage457
dc.identifier.endpage459
dc.contributor.firstauthorID21989


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster